- Home
- ESPR vs CCRN Comparison
ESPR vs CCRN Comparison
Compare ESPR & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- CCRN
- Stock Information
- Founded
- ESPR 2008
- CCRN 1986
- Country
- ESPR United States
- CCRN United States
- Employees
- ESPR N/A
- CCRN N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- CCRN Professional Services
- Sector
- ESPR Health Care
- CCRN Consumer Discretionary
- Exchange
- ESPR Nasdaq
- CCRN Nasdaq
- Market Cap
- ESPR 445.6M
- CCRN 447.2M
- IPO Year
- ESPR 2013
- CCRN N/A
- Fundamental
- Price
- ESPR $2.76
- CCRN $13.14
- Analyst Decision
- ESPR Buy
- CCRN Hold
- Analyst Count
- ESPR 6
- CCRN 5
- Target Price
- ESPR $6.50
- CCRN $17.93
- AVG Volume (30 Days)
- ESPR 6.0M
- CCRN 368.8K
- Earning Date
- ESPR 11-06-2025
- CCRN 11-05-2025
- Dividend Yield
- ESPR N/A
- CCRN N/A
- EPS Growth
- ESPR N/A
- CCRN N/A
- EPS
- ESPR N/A
- CCRN N/A
- Revenue
- ESPR $268,125,000.00
- CCRN $1,192,539,000.00
- Revenue This Year
- ESPR $9.87
- CCRN N/A
- Revenue Next Year
- ESPR N/A
- CCRN N/A
- P/E Ratio
- ESPR N/A
- CCRN N/A
- Revenue Growth
- ESPR N/A
- CCRN N/A
- 52 Week Low
- ESPR $0.69
- CCRN $9.58
- 52 Week High
- ESPR $3.94
- CCRN $18.33
- Technical
- Relative Strength Index (RSI)
- ESPR 71.69
- CCRN 48.11
- Support Level
- ESPR $2.69
- CCRN $11.09
- Resistance Level
- ESPR $2.85
- CCRN $13.37
- Average True Range (ATR)
- ESPR 0.17
- CCRN 0.65
- MACD
- ESPR -0.00
- CCRN -0.07
- Stochastic Oscillator
- ESPR 82.72
- CCRN 63.86
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.